RecruitingPhase 1 / Phase 2NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Sponsor: Sumitomo Pharma America, Inc.
Newport Beach, CA · Palo Alto, CA · +31 more sites
1 recruiting leukemia studies with a site in Newport Beach, CA.
Sponsor: Sumitomo Pharma America, Inc.
Newport Beach, CA · Palo Alto, CA · +31 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.